Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate

Wednesday, May 29, 2013

Save the Date! Hep B United Launch Event—June 12, 2013 Washington DC

 
Save the Date!
Hep B United Launch Event
 
When:
June 12, 2013
9:00-11:00am EDT
 
Where:
The Hubert H. Humphrey Building
200 Independence Avenue S.W.
Washington, D.C., 20201
 
Who:
Local and National Viral Hepatitis Advocates
 
What:   
Hep B United, in collaboration with the Department of Health and Human Services and the White House Initiative on Asian Americans and Pacific Islanders, and in partnership with the Centers for Disease Control and Prevention, invites you to an upcoming event to celebrate successes around the prevention, care, and treatment of hepatitis B and to launch a new nationwide campaign to continue to promote awareness about this disease!

Your presence would be greatly appreciated and we look forward to seeing you there! Please contact Isha Weerasinghe at iweerasinghe@aapcho.or to RSVP by Friday, June 7th or if you have any questions related to this event.


About Hep B United
Hep B United is a national campaign to address the public health challenge of hepatitis B. The goal of Hep B United is to support local community coalition efforts across the U.S. to increase hepatitis B awareness, screening, vaccination and linkage to care for all Americans, but in particular, for high-risk Asian American and Pacific Islander populations who are disproportionately impacted. For more information on Hep B United, please visit http://hepbunited.org.

No comments:

Post a Comment